Olfactory Deficits in MCI as Predictor of Improved Cognition on Donepezil

NCT01845636 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Mild Cognitive Impairment

Interventions

DRUG: Donepezil
DRUG: Atropine

Sponsor

New York State Psychiatric Institute

Collaborators

[object Object]